Figure 3

Survival of DS-ALL patients treated according to the NOPHO ALL-1992 and ALL-2000 protocols in relation to WBC counts <50 × 109/l vs. ≥50 × 109/l. (a) Event-free survival. (b) Overall survival.
Survival of DS-ALL patients treated according to the NOPHO ALL-1992 and ALL-2000 protocols in relation to WBC counts <50 × 109/l vs. ≥50 × 109/l. (a) Event-free survival. (b) Overall survival.